OmniAb (OABI) Total Debt (2021 - 2026)
OmniAb (OABI) reported Total Debt of $1.0 million for Q1 2026, up 183.85% year-over-year from $353000.0 in Q1 2025, and down 4.02% on a QoQ basis from $1.0 million in Q4 2025.
OmniAb (OABI) has 6 years of Total Debt data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Total Debt rose 183.85% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 183.85% YoY) and the FY2025 annual result came in at $1.0 million, up 96.61% from the prior year.
- Total Debt retreated to $1.0 million in Q1 2026 per OABI's latest filing, from $1.0 million in the prior quarter.
- Across five years, Total Debt topped out at $4.0 million in Q4 2022 and bottomed at $42631.0 in Q1 2022.
- The 5-year median for Total Debt is $891000.0 (2024), against an average of $1.1 million.
- The widest annual swing landed in 2022, when Total Debt jumped 1153220.0%; it then sank 88.33% in 2024.
- Tracing OABI's Total Debt over 5 years: stood at $4.0 million in 2022, then slumped by 67.6% to $1.3 million in 2023, then tumbled by 59.25% to $531000.0 in 2024, then soared by 96.61% to $1.0 million in 2025, then declined by 4.02% to $1.0 million in 2026.
- Per Business Quant, the three latest OABI Total Debt figures stand at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $719000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 719,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 353,000.00 |
| Dec 31, 2024 | 531,000.00 |
| Sep 30, 2024 | 510,000.00 |
| Jun 30, 2024 | 328,000.00 |
| Mar 31, 2024 | 891,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 88,294.00 |
| Jun 30, 2022 | 57,666.00 |
| Mar 31, 2022 | 42,631.00 |
| Dec 31, 2021 | 2.54 Mn |
| Jun 30, 2021 | 5.00 |